[ TRANSACTION RECORD ]

EQT AB Investment in Dechra Pharmaceuticals — 2023

VERIFIED VECTOR ID: 001482 · tx-010
M SOURCE NODE — FUNDER
EQT AB
Finance Sweden
$5,600,000,000
EQUITY
02/06/2023
Q DESTINATION NODE — RECIPIENT
Dechra Pharmaceuticals
Company United Kingdom
Amount (USD)
$5.6B
Flow Type
EQUITY
Transaction Date
02/06/2023
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity EQT AB
AUM 250000
HQ Location Sweden
Sector Finance
Recipient Profile [ Q ]
Entity Dechra Pharmaceuticals
Entity Type Company
Jurisdiction United Kingdom
Intelligence Note

EQT AB agreed to acquire Dechra Pharmaceuticals for approximately 5.6 billion dollars, taking the specialized veterinary business private. The transaction is intended to support Dechra’s next phase of growth through increased R&D and geographic expansion. This deal reflects the high institutional demand for resilient healthcare and animal health assets.

Σ
Primary Forensic Source https://www.eqtgroup.com/news/2023/eqt-to-acquire-dechra-pharmaceuticals/
✓ SOURCE LINKED